ANGPT2 and hereditary hemorrhagic telangiectasia: Accordingly, it was recently shown that blocking Ang2 (using LC10 monoclonal antibody) can prevent or reduce AVMs and other HHT-associated abnormalities in mice (96, 97) (Figure 3).